Skip to content
MedsAcross

Fixed-dose combination

Benzoyl peroxide and Erythromycin

Also known as benzoyl peroxide, erythromycin
Available on requestCold chain
Presentations
3
Brands
1
Manufacturers
1
Available from stock
0

Benzoyl peroxide and Erythromycin is a fixed-dose combination of a macrolide antimicrobial and a macrolide indicated for the topical treatment of acne vulgaris. It is available as kits and gel for topical use. MedsAcross supplies Benzoyl peroxide and Erythromycin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Key facts

Pharmacological class
Macrolide, Macrolide Antimicrobial, Decreased Sebaceous Gland Activity
US FDA first approval
26 October 1984
EU status
Not recorded
Orphan designation
Not recorded
WHO essential medicine
Not recorded
India (CDSCO)
Not yet confirmed against CDSCO approval lists
Routes
Topical
Dosage forms
Kit, Gel
Fixed-dose combination of
Benzoyl peroxide, Erythromycin
Identifiers
RxCUI 392556Q48566715

Clinical information

From the regulator-approved product information. Each section names its source.

Dosing overview

Benzamycin Topical Gel should be applied twice daily, morning and evening, or as directed by a physician, to affected areas after the skin is thoroughly washed, rinsed with warm water and gently patted dry.

Source: US FDA prescribing information

Contraindications

Benzamycin Topical Gel is contraindicated in those individuals who have shown hypersensitivity to any of its components.

Source: US FDA prescribing information

Warnings and precautions

Pseudomembranous colitis has been reported with nearly all antibacterial agents, including erythromycin, and may range in severity from mild to life-threatening. Therefore, it is important to consider this diagnosis in patients who present with diarrhea subsequent to the administration of antibacterial agents. Treatment with antibacterial agents alters the normal flora of the colon and may permit overgrowth of clostridia. Studies indicate that a toxin produced by Clostridium difficile is one primary cause of “antibiotic-associated colitis”. After the diagnosis of pseudomembranous colitis has been established, therapeutic measures should be initiated. Mild cases of pseudomembranous colitis usually respond to drug discontinuation alone.

Source: US FDA prescribing information

Side effects

In controlled clinical trials, the incidence of adverse reactions associated with the use of Benzamycin Topical Gel was approximately 3%. These were dryness and urticarial reaction. The following additional local adverse reactions have been reported occasionally: irritation of the skin including peeling, itching, burning sensation, erythema, inflammation of the face, eyes and nose, and irritation of the eyes. Skin discoloration, oiliness and tenderness of the skin have also been reported.

Source: US FDA prescribing information

Storage

Add indicated amount of room temperature 70% ethyl alcohol to vial (to the mark) and immediately shake to completely dissolve erythromycin. Benzamycin Topical Gel should then be stored under refrigeration. Do not freeze. Do not freeze. NOTE: Prior to reconstitution, store at room temperature between 15° to 30°C (59° to 86°F). After reconstitution, store under refrigeration between 2° to 8°C (36° to 46°F).

Source: US FDA prescribing information

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

All presentations

3 presentations of Benzoyl peroxide and Erythromycin, sorted by availability.

MedicineActive ingredientManufacturerRegisterAvailability
Benzoyl peroxide and Erythromycin kitGeneric nameBenzoyl peroxide and Erythromycin—US FDAAvailable on request
Benzoyl peroxide and Erythromycin 50 mg/30 mg per g gelTopical Cold chainGeneric nameBenzoyl peroxide and Erythromycin—US FDAAvailable on request
Benzamycin kit Cold chainBenzoyl peroxide and ErythromycinBausch HealthUS FDAAvailable on request

Brands by market

1 brand names across 1 markets.

Brand names by country

United States

Manufacturers

Regulatory status

Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.

RegisterStatusSource
US FDAFirst approved 26 October 1984Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Questions and answers

Is Benzoyl peroxide and Erythromycin available for export from India?

Yes, on request. MedsAcross lists 3 presentations of Benzoyl peroxide and Erythromycin and sources them for licensed hospitals, importers and physicians against valid import documents.

What brand names does Benzoyl peroxide and Erythromycin have?

The catalogue lists 1 brand names for Benzoyl peroxide and Erythromycin, including Benzamycin.

Is Benzoyl peroxide and Erythromycin approved by the US FDA?

Yes. The US FDA first approved Benzoyl peroxide and Erythromycin on 26 October 1984, according to Drugs@FDA.

Does Benzoyl peroxide and Erythromycin need cold chain shipping?

At least one listed presentation of Benzoyl peroxide and Erythromycin must be kept cold, so it is shipped in temperature-controlled packaging. Check the storage line on each presentation.

References

  1. Benzamycin prescribing information (Bausch Health). U.S. National Library of Medicine, DailyMed. Retrieved 30 November 2020

Request Benzoyl peroxide and Erythromycin for export supply

Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.